SIA
IRMD icon

Sit Investment Associates’s iRadimed IRMD Stock Holding History

Sit Investment Associates’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$332K Hold
3,450
– – 0.01% 419
2025
Q4 		$336K Hold
3,450
– – 0.01% 429
2025
Q3 		$246K Hold
3,450
– – 0.01% 438
2025
Q2 		$206K Hold
3,450
– – ﹤0.01% 451
2025
Q1 		$181K Buy
+3,450
New +$194K ﹤0.01% 454

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sit Investment Associates's IRMD Position: Q1 2026 in Review

Sit Investment Associates held its iRadimed (IRMD) position steady in Q1 2026 at 3,450 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #419.

Sit Investment Associates first reported a position in IRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $336K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Sit Investment Associates held 3,450 shares of iRadimed worth $332K as of Q1 2026.
  • Sit Investment Associates left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up 0.01% of Sit Investment Associates's portfolio in Q1 2026, its #419 holding.
  • Sit Investment Associates first reported a position in iRadimed in Q1 2025 and has held it in 5 quarters since.
  • Sit Investment Associates's iRadimed position peaked at $336K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.